biomark diagnostics color logo medium
  • News

BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer

BioMark Diagnostics Inc.
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

Sept 9thBioMark Diagnostics Receives Clearance from Health Canada (PDF)

 

———————————————

Share this post:
Share on facebook
Share on twitter
Share on linkedin
Share on email
Categories
Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
CSE: BUX
OTC: BMKDF
FSE: 20B
More Information
Investors

Related articles ...

biomark-diagnostics-logo-medium2

1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2

Pages
Latest Posts
Site Policies

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.

Twitter
Linkedin